Darlene Dobkowski, Managing Editor for CURE® magazine, has been with the team since October 2020 and has covered health care in other specialties before joining MJH Life Sciences. She graduated from Emerson College with a Master’s degree in print and multimedia journalism. In her free time, she enjoys buying stuff she doesn’t need from flea markets, taking her dog everywhere and scoffing at decaf.
Emerging Therapies Show Promise in Treating Metastatic Breast Cancer
March 16th 2021An expert discusses the potential that several novel therapies hold in treating metastatic breast cancer, including PARP inhibitors, immunotherapy and antibody drug conjugates. Each therapy type has an FDA-approved option to potentially provide patients with better outcomes and quality of life.
Read More
Looking at the Big Picture of Small Cell Lung Cancer
March 10th 2021An expert discusses ways that small cell lung cancer is diagnosed, how to treat it and how to pivot if the disease spreads or recurs. He also focuses on efforts in the clinical trial space to potentially treat patients more effectively.
Read More
Death From Heart-Related Causes May Affect Cancer Survivors More Than the General Population
March 8th 2021More than half of the deaths assessed in this study were related to non-cancer-related causes such as cardiovascular disease compared with cancer-related causes, which may reflect a need for risk factor management for heart disease during survivorship.
Read More
Educating Others With Clinical Knowledge and Personal Experience
March 1st 2021Although a gynecologic oncologist has spent a good part of her career helping patients during their cancer journeys, she took it upon herself to take one step further to educate women on how they can advocate for themselves and potentially prevent cancer before it impacts their lives.
Read More
Oncologist Turned Caregiver Offers Guidance About Women's Cancers
February 25th 2021In this episode of the “CURE Talks Cancer” podcast, we spoke with a gynecologic cancer expert about how her sister’s journey with ovarian cancer provided her with a different perspective that would lead to raising awareness for others.
Read More
A higher starting dose of Lenvima, compared with a lower starting dose, prolonged the time that patients with renal cell carcinoma experienced negative effects on factors including social and physical functioning, financial difficulties and cogitative functioning over time.
Read More
Patients With Lung Cancer May Need More Support, Education When Making Treatment Decisions
January 29th 2021In a survey conducted by the Cancer Support Community, 33% of patients with lung cancer reported they were somewhat or not at all involved in the decision-making process, and 66% were not as knowledgeable about their treatment options as needed to make this decision.
Read More
Chemotherapy With Immunotherapy Improves Overall Survival for Extensive-Stage Small Cell Lung Cancer
January 27th 2021Tecentriq with carboplatin and etoposide led to a median overall survival rate of 12.3 months versus 10.3 months in those assigned placebo, carboplatin and etoposide, although the death rate was high at a median follow-up of 22.9 months.
Read More